BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

RESVERLOGIX — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report

RESVERLOGIX

via CANNAE POLICY GROUP LLC

2nd Quarter (Apr 1 - June 30) · 2019Posted Jul 21, 2019Filing document ↗LDA record ↗

Income$38Kfee reported

Client

Name: RESVERLOGIX
Description: Pharmaceutical
Location: Canada

Registrant

Firm: CANNAE POLICY GROUP LLC
Description: consultant
Location: Greenville, Florida, United States of America

Lobbying activities

1 issue

Pharmacy
New pharmaceutical developments
LobbyistsROBERT BISSEN · mr ALLEN BOYD
TargetedHealth & Human Services, Dept of (HHS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.